Diacerein has a weak effect on the catabolic pathway of human

Diacerein is an inhibitor of pro-inflammatory cytokine Interleukin-1B production, prescribed for osteoarthritis and chronic inflammatory arthritis

Diacerein A Viewpoint by Bernard Mazieres Adis New Drug Profile Cite this article Mazieres, B Diacerein Drugs 53, 108 https

diacerein Diacerein is a symptomatic slow-acting drug in osteoarthritis and the active metabolite is rhein It is a non-steroidal anti-inflammatory drug

diacerein CONCLUSIONS: Diacerein was as effective as piroxicam in reducing pain and improving function but, unlike piroxicam, displayed a carry-over effect and a better